-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, OsCWKmBtSzB+IU3shG4gr7afHEpPLh34W3fkCJnt3yXe9IDPnh56VrmCOJJrql91 MsqMvNGXf+9sNeG/6HQb3A== 0001104659-05-047150.txt : 20051004 0001104659-05-047150.hdr.sgml : 20051004 20051004173940 ACCESSION NUMBER: 0001104659-05-047150 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20050930 FILED AS OF DATE: 20051004 DATE AS OF CHANGE: 20051004 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SUNESIS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001061027 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943295878 BUSINESS ADDRESS: STREET 1: 341 OYSTER POINT BOULEVARD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-266-3500 MAIL ADDRESS: STREET 1: 341 OYSTER POINT BOULEVARD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: MOSAIC PHARMACEUTICALS INC DATE OF NAME CHANGE: 19980709 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LEFF JONATHAN S CENTRAL INDEX KEY: 0001215242 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51531 FILM NUMBER: 051122873 BUSINESS ADDRESS: STREET 1: WARBURG PINCUS & CO STREET 2: 466 LEXINGTON AVE CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 2128789219 MAIL ADDRESS: STREET 1: C/O WARBURG PINCUS STREET 2: 466 LEXINGTON AVENUE CITY: NEW YORK STATE: NY ZIP: 10017 4 1 a4.xml 4 X0202 4 2005-09-30 0 0001061027 SUNESIS PHARMACEUTICALS INC SNSS 0001215242 LEFF JONATHAN S C/O SUNESIS PHARMACEUTICALS, INC. 341 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 1 0 1 0 Common Stock 2005-09-30 4 C 0 1442595 0.00 A 1442595 I See Footnotes Common Stock 2005-09-30 4 C 0 934127 0.00 A 934127 I See Footnotes Common Stock 2005-09-30 4 P 0 445000 7.00 A 1379127 I See Footnotes Common Stock 2 I By Daughter Common Stock 2 I By Son Series B Preferred Stock 2005-09-30 4 C 0 1326617 0.00 D Common Stock 1442595 0 I See Footnotes Series C Preferred Stock 2005-09-30 4 C 0 473531 0.00 D Common Stock 934127 0 I See Footnotes All outstanding shares of Preferred Stock were automatically converted into shares of Common Stock upon the closing of the Issuer's Initial Public Offering ("IPO"). Reflects a reverse stock split that occurred in connection with the Issuer's IPO. Shares held by Warburg, Pincus Equity Partners, L.P., a Delaware limited partnership. Shares held by Warburg, Pincus Equity Partners, L.P., a Delaware limited partnership, and two affiliated partnerships (collectively, "WPEP"). Warburg Pincus Partners LLC, a New York limited liability company ("WPP LLC") and a subsidiary of Warburg Pincus & Co., a New York general partnership ("WP"), is the general partner of WPEP. WPEP is managed by Warburg Pincus LLC, a New York limited liability company ("WP LLC"). The reporting person is a general partner of WP and a managing director and member of WP LLC, and therefore, may be deemed to have an indirect pecuniary interest over these shares. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. By reason of the provisions of Rule 16a-1 of the Securities Exchange Act of 1934, as amended, each of WPEP, WPP LLC, WP and WP LLC may be deemed to be the beneficial owner of all of the shares of Common Stock owned by WPEP. Each of WPP LLC, WP and WP LLC disclaim beneficial ownership of all shares of the Common Stock that will be owned by WPEP, except to the extent of any indirect pecuniary interest therein. Shares of Preferred Stock were convertible into shares of Common Stock at any time and had no expiration date. WPEP purchased an additional 445,000 shares of Common Stock in connection with the Issuer's IPO. Daryl B. Winter, as attorney-in-fact for Jonathan S. Leff 2005-10-04 -----END PRIVACY-ENHANCED MESSAGE-----